Navidea Biopharmaceuticals has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for the approval to market and sale Lymphoseek Injection for sentinel lymph node (SLN) detection in patients ...
Ventana Medical Systems (Ventana), a member of the Roche Group, has announced that its Ventana HER2/neu (4B5) rabbit monoclonal primary antibody assay is now a companion diagnostic for detecting HER2 protein expression for patients who, in ...
Tags: Ventana, Medical Systems
US-based Agios Pharmaceuticals has announced an extension of one additional year to the period of exclusivity for their strategic cancer metabolism collaboration with Celgene. Celgene research president Dr Thomas Daniel noted the quality ...
A study has found diesel fumes could be responsible for as many as six per cent of all lung cancer deaths in the UK and USA. Researchers from the University of Utrecht in the Netherlands published a study that found people exposed to ...
Tags: Diesel Fumes, Lung Cancer Risk
Novian Health, the developer of Novilase breast therapy, has announced the issuance of a new US patent covering the interstitial laser therapy in combination with interstitial brachytherapy treatment. Novian Health has developed the ...
Tags: Novian Health, Breast Cancer
Ventana Medical Systems, a member of the Roche Group, has obtained the US Food and Drug Administration’s (FDA) 510(k) approval for its Companion Algorithm ER (SP1) image analysis algorithm used with the Ventana iScan Coreo scanner ...
Tags: Breast Cancer, Analysis Algorithm
OncoMed Pharmaceuticals and Celgene have entered into an agreement to jointly develop and commercialize about six anti-cancer stem cell (CSC) product candidates from OncoMed's biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). ...
Tags: clinical studies, Medicine, OncoMed
Sumitomo Heavy Industries has obtained the US Food and Drug Administration (FDA) 510(k) clearance of its Proton Therapy System, a form of radiation therapy, which employs proton beams to kill cancer cells with better dose distribution in ...
Tags: Proton Therapy System, Sumitomo
Navidea Biopharmaceuticals will collaborate with the University of Alabama at Birmingham (UAB) on a clinical study that will assess the safety and activity of a radiolabeled, humanized monoclonal antibody from its RIGS (radio-immuno-guided ...
Myriad Genetics, a molecular diagnostic company, and biotechnology firm BioMarin Pharmaceutical have signed a research collaboration agreement for identifying tumor types that may be sensitive to BioMarin's investigational product ...
Tags: Myriad Genetics, Biomarin
Waste-water treatment by-products, also known as sewage sludge, are frequently used as fertilizer. And that means whatever this stew of sewage leftovers contains, including substances hazardous to human and animal health, could potentially ...
Tags: antibiotic, resistant, bacteria, fertilizer, super bug
"There is not one, but many cures for cancer available. But they are all being systematically suppressed by ... the major oncology centers. They have too much of an interest in the status quo," stated Dr Robert Atkins, MD, creator of the ...
Preliminary studies identified the presence of breast cancer cells from serum biomarkers indicating a blood test may be possible, U.S. researchers say. Study leader biomedical engineer Tony Hu of Houston Methodist Research Institute in ...
NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has announced the availability of the nCounter Dx analysis system for high-complexity, CLIA-certified laboratories. ...
Tags: NanoString, DX Analysis System
Switzerland-based Helsinn group has granted Chugai Pharma Marketing, a wholly-owned subsidiary of Chugai Pharmaceutical, exclusive commercialization rights to their ghrelin receptor agonist, anamorelin, for the three major European pharma ...
Tags: Helsinn group, Pharma Marketing